Publication
Article
Oncology Live®
Pharma Tech: Eli Lilly and Company
Author(s):
The PharmaTech section highlights online information and educational resources created by leading pharmaceutical companies. This month, we spotlight several resources from Eli Lilly and Company.
This website is intended as a source of information for healthcare professionals who are treating patients with ADHD. It also provides information for patients, family members, and educators to help them better understand the disorder. The “For Parents & Caregivers” section provides answers to several commonly asked questions about ADHD, including “What is ADHD?” “How can ADHD be treated?” and “What can I do to help?” The answers review topics ranging from symptoms and behavior modification to parenting resources and quick facts. Visitors can complete a registration form and sign up to receive e-mailed suggestions about how to manage ADHD and up-to-date treatment and research news.
Patients who are interested in learning more about the clinical trials sponsored by Eli Lilly and Company and featuring one of the company’s pharmaceutical treatments can visit this website to learn more about the various types of clinical trials (eg, open-label study, doubleblind study) and the terminology associated with them. Patients can also search for open trials and read summaries of completed trials. When performing a search, patients can view trials by therapeutic area (eg, cardiology, endocrinology, neuroscience) or by the specific Eli Lilly and Company product being tested. Links to other clinical trial search engines are provided, as well as links to the FDA and World Health Organization websites.
At this website, healthcare professionals will find information about Lilly medications used to treat more than a dozen medical conditions, ranging from schizophrenia and osteoporosis to Turner syndrome and adult growth hormone
deficiency. Click on the name of a medical condition to view a list of websites containing information about the condition and related resources; some also include patient education resources, clinical reimbursement information, and interactive learning tools.
Direct your diabetic patients to this online resource to learn more about the disease and the Lilly products used to treat it. The site features three sections devoted to providing information about insulin: “Deciding to Take Insulin,” “Using Insulin,” and “Getting the Most From Insulin.” Also provided are print-friendly .PDF files containing prescribing, safety, and patient product information for nine insulin products developed by Lilly. Patients interested in receiving diabetes treatment and management e-mail updates can click “Sign up for E-mail Updates.” The website can also be viewed in Spanish.
The site is organized into nine main sections, with sub-sections devoted to important information about disease states and the Lilly medications available to treat them. Visitors will find information about each drug’s dosing, delivery, and formulation; side effects; and safety profile. Also available are links to Lilly’s grant office, information about clinical trials, and prescribing information for each product profiled. To access the website, registration is required.
View these webcasts to learn more about the disease states treated by Lilly products.
Originally aired on May 14, this webcast features a presentation given by Russell A. Barkley, PhD, Research Professor of Psychiatry at the State University of New York Upstate Medical University in Syracuse, about recent advancements in ADHD management and our understanding of the inattentive and hyperactive- impulsive ADHD subtypes. Barkley also reviews the affect coexisting disorders (eg, anxiety, conduct disorder, sleep disorder) can have on children, adolescents, and adults diagnosed with ADHD.
Bipolar Treatment: Integration of Study Data and Clinical Guidelines
Dr. John Cookson, Consultant and Honorary Senior Lecturer in Psychiatry, The Royal London Hospital, United Kingdom, discussed recently developed bipolar disorder treatments and the outcomes for people with bipolar disorder during this May 11 European Live Internet Conference. Cookson mainly focused on “how study results and clinical guidelines, such as study results and clinical guidelines within the [National Institute for Health and Clinical Excellence] NICE guideline, can be integrated in clinical practice.
